| Literature DB >> 35873088 |
Chanjuan Yue1, Wanjing Yang1, Yunli Li1, Dongsheng Zhang1, Jingchao Lan1, Xiaoyan Su1, Lin Li1, Yiyan Liu1,2, Weichao Zheng3, Kongju Wu1, Xueyang Fan1, Xia Yan1, Rong Hou1, Songrui Liu1.
Abstract
Toxoplasma gondii is a worldwide-distributed zoonotic protozoan parasite which causes toxoplasmosis and has a significant effect on public health. In the giant panda (Ailuropoda melanoleuca), toxoplasmosis can cause asymptomatic infections, reproductive disorder and even death, which poses a serious threat to the conservation of this rare protected species. Therefore, serological investigation of T. gondii is essential to understanding its risk to giant pandas, however, there are no specific testing kits for giant pandas. Previous research has used MAT as the reference method for screening T. gondii, to investigate this further, this study focused on the agreement comparing of MAT with ELISA and IHA tests for detecting T. gondii antibodies in 100 blood samples from 55 captive giant pandas in Chengdu, China. The results showed 87.0%, 87.0%, 84.0%, samples were sero-positive for T. gondii using ELISA (kits a, b, c), respectively, while MAT and IHA tests were 84.0% and 9.0% sero-positive, respectively. There was no significant difference between MAT and the three ELISA kits and these two methods had substantial agreement (0.61 < қ ≤ 0.80). Meanwhile, there was a significant difference (P < 0.001) between MAT and IHA, and these two methods had only a slight agreement (қ ≤ 0.20). The relative sensitivity of the ELISA (kits a, b, c) were 89.0%, 91.5% and 95.1%, and the specificity were 86.7%, 80.0% and 80.0%, respectively, which showed these three ELISA kits all had great accuracy. It is suggested that MAT is the recommended test method for primary screening T. gondii in giant pandas and then verified by ELISA.Entities:
Keywords: ELISA; Giant panda; Indirect hemagglutination assay; Modified agglutination test; Toxoplasma gondii
Year: 2022 PMID: 35873088 PMCID: PMC9305340 DOI: 10.1016/j.ijppaw.2022.07.001
Source DB: PubMed Journal: Int J Parasitol Parasites Wildl ISSN: 2213-2244 Impact factor: 2.773
The summary information of three commercial ELISA kits.
| Serological Test | Commercial kits | Conversion formula | Interpretation (Criterion) | |
|---|---|---|---|---|
| ELISA (a) | ID.Screen | Positive | S/P% ≥ 50% | |
| Doubtful | 40% < S/P% < 50% | |||
| Negative | S/P% ≤ 40% | |||
| ELISA (b) | Haitai Biological Pharmaceuticals Co., Ltd, Zhuhai, China | None | Positive | ODS > ODC × 1.1 |
| Doubtful | ODC × 0.9 ≤ ODS ≤ ODC × 1.1 | |||
| Negative | ODS < ODC × 0.9 | |||
| ELISA (c) | Tian Tech | Positive | S/P% ≥ 1.0 | |
| Negative | S/P% < 1.0 | |||
OD: optical density; S: sample; NC: negative control; PC: positive control; C: control sample.
Comparison of antibody titers to T. gondii of the IHA and MAT tests.
| IHA titer | MAT titer | Total | ||||
|---|---|---|---|---|---|---|
| <25 | 25 | 50 | 100 | 200 | ||
| <4 | 16 | 6 | 24 | 6 | 39 | 91 |
| 4 | – | – | – | – | 3 | 3 |
| 16 | – | 2 | – | – | – | 2 |
| 64 | – | – | – | – | – | 0 |
| 256 | – | – | – | – | 4 | 4 |
| Total | 16 | 8 | 24 | 6 | 46 | 100 |
Cross-classification, sero-prevalence and error rate of three serological tests.
| MAT | IHA | ELISA(a) | ELISA(b) | ELISA(c) | |||||
|---|---|---|---|---|---|---|---|---|---|
| + | – | + | – | + | – | + | – | ||
| Cross-classification | + | 9 | 75 | 81 | 1 | 80 | 2 | 80 | 4 |
| _ | 0 | 16 | 6 | 8 | 7 | 9 | 4 | 12 | |
| False negative rate (%) | 89.3 | 1.2 | 2.4 | 4.8 | |||||
| False positive rate (%) | 0.0 | 42.9 | 43.8 | 25.0 | |||||
| Sero-prevalence (%) | 84.0 | 9.0 | 87.0 | 87.0 | 84.0 | ||||
| 95% CI | 76.7–91.3 | 3.3–14.7 | 80.3–93.7 | 80.3–93.7 | 76.7–91.3 | ||||
Comparison of diagnostic performance of IHA and ELISA kits base on MAT.
| Serological test | McNemar | қ (95%CI) | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|
| χ2 | |||||
| IHA | 1.884 | 0.000** | 0.037 (0.008–0.066) | – | – |
| ELISA(a) | 44.019 | 0.125 | 0.637 (0.404–0.870) | 89.0 | 86.7 |
| ELISA(b) | 38.904 | 0.180 | 0.563 (0.508–0.896) | 91.5 | 80.0 |
| ELISA(c) | 49.337 | 1.000 | 0.702 (0.336–0.790) | 95.1 | 80.0 |
Note:**P < 0.01, The difference is highly significant.
*0.01 < P < 0.05, difference significant.
P > 0.05, no significant difference.
қ ≤ 0.20, The degree of agreement between two methods is slight.
0.21 < қ ≤ 0.40, The degree of agreement between two methods is fair.
0.41 < қ ≤ 0.60, The degree of agreement between two methods is moderate.
0.61 < қ ≤ 0.80, The degree of agreement between two methods is substantial.
0.81 < қ ≤ 1, The degree of agreement between two methods is almost perfect.
Fig. 1Receiver operating characteristics (ROC) analysis of the ELISA.
ROC analysis shows an area under the curve (AUC) of 0.861 (95% CI: 0.712–1.000) for ELISA (a), 0.894 (95% CI: 0.791–0.997) for ELISA (b), and 0.902 (95% CI: 0.799–1.000) for ELISA (c).